Exosomes in renal cell carcinoma: challenges and opportunities
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09384-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Mahan Mohammadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Exosomes, Extracellular Vesicles, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 163 Literaturangaben.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) is the most common type of kidney cancer that accounts for approximately 2-3% of adult malignancies. Among the primary treatment methods for this type of cancer are surgery and targeted treatment. Still, due to less than optimal effectiveness, there are problems such as advanced distant metastasis, delayed diagnosis, and drug resistance that continue to plague patients. In recent years, therapeutic advances have increased life expectancy and effective treatment in renal cell carcinoma patients. One of these methods is the use of stem cells. Although the therapeutic effects of stem cells, especially mesenchymal stem cells, are still impressive, today, extracellular vesicles (EVs) as carrying molecules and various mediators in intercellular communications, having a central role in tumorigenesis, metastasis, immune evasion, and drug response, and on the other hand, due to its low immunogenicity and strong regulatory properties of the immune system, has received much attention from researchers and doctors. Despite the increasing interest in exosomes as the most versatile type of EVs, the heterogeneity of their efficacy presents challenges and, on the other hand, exciting opportunities for diagnostic and clinical interventions.In the upcoming article, we will review the various aspects of exosomes' effects in the prevention, treatment, and progress of renal cell carcinoma and also ways to optimize them to strengthen their positive sides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. houshang.najafi@gmail.com.
- Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. houshang.najafi@gmail.com.
Zitieren
APA
Mohammadi, M., Mansouri, K., Mohammadi, P., Pournazari, M., & Najafi, H. (2024). Exosomes in renal cell carcinoma: challenges and opportunities. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09384-x
Vancouver
Mohammadi M, Mansouri K, Mohammadi P, Pournazari M, Najafi H. Exosomes in renal cell carcinoma: challenges and opportunities. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09384-x
BibTeX
@article{Mohammadi2024,
author = {Mohammadi, Mahan and Mansouri, Kamran and Mohammadi, Pantea and Pournazari, Mehran and Najafi, Houshang},
title = {Exosomes in renal cell carcinoma: challenges and opportunities},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09384-x}
}
EUVIMED